期刊文献+

TROP-2基因小干扰RNA转染对前列腺癌细胞黏附、迁移和侵袭的影响 被引量:3

Effects of TROP-2 down-regulation by RNA interence on invasion of human prostate cancer cell
下载PDF
导出
摘要 目的观察肿瘤相关钙信号转导蛋白-2(TROP-2)基因小干扰RNA(siRNA)转染对前列腺癌细胞黏附、迁移和侵袭的影响。方法以TROP-2基因siRNA转染人前列腺癌PC-3细胞后,分别用实时荧光定量PCR和Western blot法检测细胞TROP-2 mRNA和蛋白,用MTT法检测PC-3细胞吸光度值(以此判断细胞黏附力),以Tr-answell小室实验观察细胞的迁移、侵袭情况。结果与空载对照组相比,TROP-2 siRNA组TROP-2 mRNA的表达明显下降(P均<0.01)并呈浓度和时间依赖性(P均<0.01);与空白对照组及空载对照组相比,TROP-2 siRNA组TROP-2蛋白的表达明显下降(P均<0.01)并呈浓度和时间依赖性(P均<0.01);与空白对照组相比,TROP-2 siR-NA组细胞黏附力下降(P<0.01)并呈浓度、时间依赖性(P均<0.05);与空白对照组及空载对照组相比,TROP-2siRNA组细胞迁移、侵袭数明显减少(P均<0.01)并呈浓度依赖性(P均<0.01)。结论 TROP-2基因siRNA转染可抑制前列腺癌PC-3细胞黏附、迁移和侵袭。 Objective To explore the effects of TROP-2 gene small interfering RNA(siRNA)on adhesion,migration,and invasion of human prostate cancer cell.Methods After human prostate cancer PC-3 cell was transfected with different dose of TROP-2 siRNA,the expression of TROP-2 mRNA and protein were were determined by real-time quantitative PCR and Western blot assay,respectively.Cell adhesion was evaluated by MTT assay.The migration and invasion was exmined by Transwell,respectively.Results The results from Real-Time quantitative PCR and Western blot showed that TROP-2 mRNA and protein reduced in time-and dose-dependent manners(all P0.01).The adhesive,migrative and invasive ability of PC-3 cell treated with TROP-2 siRNA decreased compared with control groups(all P0.01).Conclusion TROP-2 gene may play a pivotal role in adhesion,migration,and invasion of human prostate cancer cell.siRNA targeted TROP-2 can inhibit adhesion,migration,and invasion of human prostate cancer cell.
出处 《山东医药》 CAS 2012年第10期17-19,共3页 Shandong Medical Journal
基金 江苏省自然科学基金资助项目(BK2011483)
关键词 前列腺肿瘤 肿瘤相关钙信号转导蛋白-2 RNA干扰 癌细胞黏附 癌细胞迁移 癌细胞侵袭 prostate carcinoma tumor-associated calcium signal transducer-2 RNA interference adhesion migration invasion
  • 相关文献

参考文献10

  • 1Ohmachi T,Tanaka F,Mimori K. Clinical significance of TROP2 expression in colorectal cancer[J].Clinical Cancer Research,2006,(10):3057-3063.doi:10.1158/1078-0432.CCR-05-1961.
  • 2HuangHuay,Groth J,Sossey-Alaoui K. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors[J].Clinical Cancer Research,2005,(12):4357-4364.
  • 3Nakashima K,Shimada H,Ochiai T. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma[J].International Journal of Cancer,2004,(06):1029-1035.
  • 4Coldren CD,Helfrich BA,Witta SE. Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines[J].Molecular Cancer Research,2006,(08):521-528.doi:10.1158/1541-7786.MCR-06-0095.
  • 5Mühlmann G,Spizzo G,Gostner J. TROP2 expression as prognostic marker for gastric carcinoma[J].Journal of Clinical Pathology,2009,(02):152-158.
  • 6Wang J,Day R,Dong Y. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers[J].Molecular Cancer Therapeutics,2008,(02):280-285.
  • 7Fire A,Xu S,Montgomery MK. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,(3669):806-811.doi:10.1038/35888.
  • 8Elbashir SM,Harborth J,Lendeckel W. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,2001,(6836):494-498.doi:10.1038/35078107.
  • 9Zhang B,Yao YF,Zhou P. Two novel mutations identified in two Chinese gelatinous drop-like corneal dystrophy families[J].Molecular Vision,2007,(14):988-992.
  • 10Balkwill F. Cancer and the chemokine network[J].Net Rev Cancer,2004,(07):540-550.

同被引文献43

  • 1杜岳峰,邢毅飞,曾甫清,陆鹏,刘先艮,肖亚军.人前列腺特异性抗原启动子调控的CXCR4-siRNA逆转录病毒载体的构建及其对前列腺癌细胞的生物学效应[J].中华肿瘤杂志,2007,29(7):489-494. 被引量:3
  • 2KANEKO H, FUKAO T, KASAHARA K, YAMADA T, KONDO N. Augmented cell death with Bloom syndrome helicase deficiency[J]. Mol Med Rep, 2011, 4: 607-609.
  • 3RAMACHANDRAN P V, IGNAEIMUTHU S. RNA interference——a silent but an efficient therapeutic tool[J]. Appl Biochem Biotechnol, 2013, 169: 1774-1789.
  • 4JIN X, SUN T, ZHAO C, ZHENG Y, ZHANG Y, CAI W, et al. Strand antagonism in RNAi: an explanation of differences in potency between intracellularly expressed siRNA and shRNA[J]. Nucleic Acids Res, 2012, 40: 1797-1806.
  • 5SELKIRK M E, HUANG S C, KNOX D P, BRITTON C. The development of RNA interference (RNAi) in gastrointestinal nematodes[J]. Parasitology, 2012, 139: 605-612.
  • 6PENG A, WANG L, FISHER L A. Greatwall and Polo-like kinase 1 coordinate to promote checkpoint recovery[J]. J Biol Chem, 2011, 286: 28996-29004.
  • 7GONDI C S, RAO J S. Concepts in vivo siRNA delivery for cancer therapy[J]. J Cell Physiol, 2009, 220: 285-291.
  • 8KIM D H, ROSSI J J. Strategies for silencing human disease using RNA interference[J]. Nat Rev Genet, 2007, 8: 173-184.
  • 9ANTHONY R V, CANTLON J D. Ribonucleic acid interference:a new approach to the in vivo study of gene function[J]. J Anim Sci, 2007, 85(13 Suppl): E18-E19.
  • 10TUSCHL T. Expanding small RNA interference[J]. Nat Biotechnol, 2002, 20: 446-448.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部